|Brand name(s), other common name(s)||Velcade®|
|Drug type||Proteasome inhibitor|
|How the drug is given||Intravenously (IV) or subcutaneous injection (SC)|
Bortezomib is FDA approved to treat people who have myeloma and people with mantle cell lymphoma who have received at least one prior therapy.
Side effects needing medical attention:Black, tarry stools; bleeding gums; blood in urine or stool; blurred vision; body aches or pain; burning, crawling, itching, numbness, prickling, ?pins and needles,? or tingling feelings; chest pain or tightness in chest; chills; confusion; faintness or lightheadedness when getting up from a lying or sitting position suddenly; cough; decreased urination; difficult or labored breathing or shortness of breath; dry mouth; fainting; fever; headache; increase in heart rate; loss of voice; lower back or side pain; nasal or ear congestion or runny nose, sneezing or sore throat; pale skin; painful or difficult urination; painful blisters on trunk of body; pinhead-sized red spots on skin; rapid breathing; sunken eyes; sweating; excessive thirst; troubled breathing with exertion; ulcers, sores or white spots in mouth; unsteadiness or awkwardness; unusual bleeding or bruising; unusual tiredness or weakness; weakness in arms, hands, legs or feet; wheezing.